Temporal Trends and Outcomes of Transcatheter versus Surgical Aortic Valve Replacement in Patients with Prior Myocardial Infarction-Reference-Cited by-同舟云学术

Temporal Trends and Outcomes of Transcatheter versus Surgical Aortic Valve Replacement in Patients with Prior Myocardial Infarction

Published:2020-02-19 Issue:2 Volume:4 Page:115-121
ISSN:2474-8706
Container-title:Structural Heart
language:en
Short-container-title:Structural Heart

Author:

Elbadawi Ayman¹^ORCID,Saad Marwan²^ORCID,Elgendy Islam Y.³^ORCID,Mahmoud Karim⁴^ORCID,Barssoum Kirolos⁵,Omer Mohamed⁶,Mahmoud Ahmed N.⁷,Hamed Mohamed⁸,Ogunbayo Gbolahan O.⁹,Paniagua David¹⁰,Khalife Wissam¹,Jneid Hani¹⁰

Affiliation:

1. Department of Cardiovascular Medicine, University of Texas Medical Branch, Galveston, Texas, USA

2. Division of Cardiology, Rhode Island Hospital, Brown Medical School, Providence, Rhode Island, USA

3. Division of Cardiovascular Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA

4. Division of Internal Medicine, Houston Medical Center, Warner Robbins, Georgia, USA

5. Department of Internal Medicine, Rochester General Hospital, Rochester, New York, USA

6. Department of Cardiovascular Medicine, University of Missouri Kansas City, Kansas City, Missouri, USA

7. Division of Cardiovascular Medicine, University of Washington, Seattle, Washington, USA

8. Department of Cardiovascular Medicine, Ain Shams University, Cairo, Egypt

9. Department of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky, USA

10. Division of Cardiovascular Medicine, Baylor School of Medicine, Houston, Texas, USA

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/24748706.2019.1704101

Reference32 articles.

1. Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery

2. Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients

3. Transcatheter or Surgical Aortic Valve Replacement for Low Surgical Risk Patients

4. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

5. FDA approves expanded indication for two transcatheter heart valves for patients at intermediate risk for death or complications associated with open-heart surgery [news release]. Silver Spring, MD: FDA; August 18, 2016. https://www.fda.gov/news-events/press-announcements/fda-approves-expanded-indication-two-transcatheter-heart-valves-patients-intermediate-risk-death-or. Accessed February 6, 2020.